8-K: Philip Morris International Reports Strong Q2 Results, Raises Full-Year Guidance

Philip Morris International announced a robust second quarter performance driven by its smoke-free business, leading to an increase in full-year guidance despite currency headwinds.

Summary

• Philip Morris International (PMI) reported its second-quarter and first-half 2024 results, showcasing strong growth in its smoke-free business.
• The smoke-free business now accounts for 38.1% of total net revenues, a 2.7 percentage point increase compared to the same quarter last year.
• PMI estimates 36.5 million adult users of its smoke-free products, up by 3.2 million since December 2023.
• Net revenues for the smoke-free business increased by 13.6% (18.3% organically), while gross profit rose by 15.6% (22.2% organically).
• Total IQOS users are estimated at 30.8 million, with 22.1 million having fully switched from smoking.
• In Japan, IQOS HTU market share exceeded 29%, with offtake share surpassing 30% in June.
• The company's nicotine pouch business, ZYN, saw a 50.3% increase in shipments in the U.S., reaching 135.1 million cans.
• Combustibles net revenues grew by 1.2% (4.8% organically), with a 40 basis point gross margin expansion.
• Reported diluted EPS grew by 52.5% to $1.54, while adjusted diluted EPS decreased by 0.6% to $1.59, but grew by 10.6% excluding currency impacts.
• PMI has raised its full-year adjusted diluted EPS guidance to $6.33-$6.45, or $6.67-$6.79 excluding currency impacts.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to strong growth in the smoke-free business, increased market share, and raised full-year guidance. While there are some challenges, the overall tone is optimistic and confident.

Positives

• The smoke-free business is experiencing strong growth, with significant increases in revenue and user base.
• IQOS is gaining market share, particularly in Japan and Europe.
• The ZYN nicotine pouch business is performing well, with substantial growth in the U.S. and other markets.
• Combustibles profitability recovered in Q2 with robust expansion of 40 bps.
• The company is raising its full-year guidance, indicating confidence in future performance.
• PMI is demonstrating strong organic growth across its smoke-free and combustible product lines.
• The company is improving its net debt to adjusted EBITDA ratio.

Negatives

• Adjusted diluted EPS decreased by 0.6% to $1.59, although it grew by 10.6% excluding currency impacts.
• The EU characterizing flavor ban impacted IQOS HTU market share in Europe, particularly in Italy.
• There are supply constraints for ZYN nicotine pouches in the U.S.
• The Wellness and Healthcare segment is still operating at a loss.
• The company is experiencing adverse currency impacts.

Risks

• Currency headwinds are impacting financial results.
• The EU characterizing flavor ban is affecting the growth of IQOS in certain European markets.
• Supply constraints for ZYN nicotine pouches could limit growth in the U.S.
• The Wellness and Healthcare segment is still in the early stages of development and is currently operating at a loss.
• The company faces risks related to regulatory restrictions, litigation, and competition.
• There are risks associated with the introduction and commercialization of smoke-free products.
• The company is subject to risks related to global economic and political developments.

Future Outlook

PMI has raised its full-year guidance, expecting a strong second-half performance, with third quarter adjusted diluted EPS of $1.77 to $1.82 including an estimated adverse currency impact of 2 cents. The company anticipates total cigarette, HTU and oral smoke-free product shipment volume growth of 1% to 2% driven by smoke-free products, and organic net revenue growth of 7.5% to 9%.

Management Comments

• The excellent momentum of our smoke-free business continued with an outstanding second-quarter and first-half performance, said Jacek Olczak, Chief Executive Officer.
• The powerful combination of excellent underlying performance and proactive measures across all categories enabled our business to outperform once again, and we are on track for a strong 2024.
• As a result, we are raising our full-year guidance, despite currency headwinds.

Industry Context

This announcement reflects the ongoing shift in the tobacco industry towards smoke-free alternatives. PMI's strong performance in this area highlights its position as a leader in the transition away from traditional cigarettes. The company's focus on innovation and expansion in smoke-free products aligns with broader industry trends and consumer preferences.

Comparison to Industry Standards

• PMI's 13.6% increase in smoke-free net revenues (18.3% organically) is a strong result compared to competitors in the tobacco industry who are also transitioning to smoke-free products.
• The 50.3% growth in ZYN nicotine pouch shipments in the U.S. demonstrates PMI's ability to compete effectively in the oral nicotine market, which is growing rapidly.
• The increase in IQOS market share in Japan to over 29% is a significant achievement, indicating strong consumer adoption of the product.
• Compared to British American Tobacco (BAT), which also reports on smoke-free product growth, PMI's results show a similar trend of strong growth in the category, but PMI is showing stronger growth in the heated tobacco category.
• The company's focus on organic growth and profitability is in line with industry best practices, as companies seek to maximize returns from their investments in smoke-free products.

Stakeholder Impact

• Shareholders will benefit from the increased full-year guidance and the declared dividend.
• Employees may see increased job security and opportunities due to the company's growth.
• Customers will have access to a wider range of smoke-free products.
• Suppliers may see increased demand for their products due to PMI's growth.
• Creditors may see improved creditworthiness due to the company's strong financial performance.

Next Steps

• PMI will continue to focus on expanding its smoke-free business and growing its user base.
• The company will continue to invest in ZYN capacity in the U.S.
• PMI will continue to target a net debt to adjusted EBITDA ratio of around 2x by the end of 2026.
• The company will monitor the impact of the EU characterizing flavor ban on its European business.
• PMI will continue to appeal the German tax surcharge on HTUs.

Key Dates

Keywords

Philip Morris International, smoke-free products, IQOS, ZYN, nicotine pouches, heated tobacco units, HTU, combustibles, earnings, EPS, financial results, market share, guidance, dividend